When mothers initially feed their babies, they make them lie on their laps, however, the same position may not be safe when the baby is feeding off the bottle.
It is important to feed your baby through the bottle in a semi-upright position and support their head. Do not feed them lying down, as formula or the milk from the bottle can flow into the middle ear, and cause infection. Also, unlike breast and its nipple, the bottle does not have the mechanism to ensure that milk is being overflowed. Also, in order to prevent your little ones from swallowing air as they suck, tilt the bottle so that the formula fills the neck of the bottles and covers the nipple.
While some babies happily drink from any bottle, some are much pickier. Yes, you read it right, babies need different bottles, based on how their bodies react after being fed.
If you have a baby with gas, it is best to try a bottle with a venting system. Now, this allows your baby to avoid air in the milk while feeding. Such bottles mimic the shape and feel of a breast or an actual nipple. Bottles with fewer parts are also easier to clean, which could be great during the middle-of-the-night feedings.
For new moms, it is also a great advice to start with a slow-flow nipple to avoid overwhelming your baby and switch to a faster flow when they seem to hold the bottle themselves and can finish milk in less time.
As per the National Health Scheme (UK), NHS UK, it is important to be prepared to experiment well with the kind of bottles that suits your baby the best. Thee is no evidence that only one type of teat or bottle is better than any other.
It is always best to ensure that you screw the top tightly into the bottle before you feed your baby.
Bottle feeding is more than just feeding and nourishing your baby, it is also an opportunity to bond with your babies. Babies also feel secure when their caregivers are feeding. This is why it is important that even before you start bottle feeding, you first find a comfortable spot to sit with your baby close to you. Look at them and gently hold the and talk as you feed.
Hold your baby in a semi-upright position during bottle feeds, with their head supported. This ensures they can breathe and swallow comfortably. Brush the teat gently against their lips, and when they open their mouth wide, let them draw the teat in.
Take your time—babies feed at their own pace, so be patient and allow them plenty of time to enjoy their meal.
Always supervise your baby during feeding sessions. Do not prop the bottle or leave them alone with it. This can also cause choking hazard, or the milk could pool in their mouth which could increase ear infections.
The bottle's position matters as much as baby's position. When feeding, hold the bottle in a horizontal position, tipping it slightly. This helps the milk flow steadily and reduces the amount of air your baby may swallow. If the teat flattens, gently pull the corner of your baby’s mouth to release the suction. Should the teat become blocked, replace it with a fresh, sterile one.
Credit: iStock
As oncologists, we often meet patients at some of the most difficult moments of their lives. Yet there are times where a patient's journey reminds of the extraordinary resilience that people can show while facing the challenges that cancer presents
I recently treated a 38-year-old woman whose story has stayed with me.
Having just welcomed her baby into the world, her demanding yet joyful routine revolved around feeding schedules and sleepless nights. It was during this period that she noticed a hard lump in her breast.
A sonomammography revealed a suspicious BIRADS 4A lesion. A biopsy confirmed Triple-Negative Breast Cancer (TNBC), which is one of the more aggressive forms of breast cancer. It was classified as a Stage III disease after evaluation through PET-CT which showed involvement of the axillary lymph nodes. The tumor also had a high Ki-67 index, indicating that it was growing rapidly.
The untimely diagnosis found the mother facing difficult questions about cancer treatment, her future and her ability to care for her child. One of the immediate challenges was that she had to stop breastfeeding.
Under the guidance of her pediatrician, her baby was transitioned to bottle feeds. This can be an emotionally challenging process for mothers as the feeling of guilt tends to seep in when breastfeeding plans are disrupted by illness.
After detailed and prolonged discussions with the patient and her family, we initiated treatment with neoadjuvant immunotherapy using pembrolizumab in combination with chemotherapy. This approach has emerged as one of the more prominent advances in the treatment of high-risk Triple-Negative Breast Cancer, having significantly improved outcomes for many patients.
Motherhood is a physically and emotionally taxing experience but the patient showed incredible strength during her cancer therapy, driven by her child and the unwavering support of her family.
Following completion of neoadjuvant therapy, repeat PET-CT imaging showed a near-complete response. She subsequently underwent surgery, and the final pathology report revealed a pathological complete response, meaning no residual invasive cancer had been detected.
This was the desired outcome for the treating team as well as the patient. She later completed the remaining course of immunotherapy, bringing her total treatment duration to one year. Today, both mother and child are doing well.
This tremendous journey highlights an important message. The fact that breast cancer can occur during pregnancy and the postpartum period deserves wider attention. Any breast lump that persists or feels unusual should be evaluated by a healthcare professional, as early diagnosis remains one of the most important factors in achieving positive outcomes.
The process is reflective of the advances in cancer treatment that are changing the outlook for patients with aggressive cancers. These advances are done through the integration of immunotherapy into treatment protocols which is helping more patients achieve improved long-term outcomes. The mother’s story is a reminder that cancer and motherhood are not mutually exclusive journeys.
Her ability to navigate this path is due to her timely diagnosis, access to appropriate treatment, family support and personal resilience. What began as a frightening diagnosis soon after childbirth ultimately became a story of hope, courage and survival. This is a powerful reminder to every new mother who might discover an unusual breast lump, that listening to your body and seeking medical advice early can make all the difference.
Credit: iStock
Pregnancy should not be regarded as a physical journey since it is a very emotional and deeply transformative phase in any woman's life. As the body changes itself to support new life, expecting mothers usually experience pain in the back, fatigue, and breathing-related discomfort. When practised under proper medical guidance, prenatal yoga can be very safe and highly supportive throughout pregnancy.
As pregnancy progresses, the center of gravity of the body is shifted by the growing uterus. This can even impact posture and overall movement of the body. Prenatal Yoga normally includes gentle stretches and a controlled level of movement, which helps to improve the flexibility and stability without even placing unnecessary strain on the mother's and baby's bodies.
Credit: Canva
India’s Union Ministry of Health and Family Welfare has issued a notification ending the over-the-counter (OTC) sale of all syrups, including cough syrups.
Under the new rules, a doctor's prescription will now be required to purchase cough syrups across the country.
“Consequently, the sale and dispensing of cough syrups in smaller villages will now be required to take place only through duly licensed pharmacies in accordance with the provisions of the Drugs and Cosmetics Act, 1940 and the Rules framed thereunder,” the notification said.
The amendment comes months after contaminated cough syrups were linked to the deaths of 22 children in Madhya Pradesh and Rajasthan, raising fresh concerns over the safety and regulation of commonly used liquid medicines.
Following the incident last year, health authorities in India had banned three cough syrups Coldrif, Respifresh TR and ReLife after traces of diethylene glycol (DEG) were detected in the products. The Coldrif contamination was linked to the deaths of 22 children in the country.
“The amendment has been undertaken to strengthen regulatory oversight of syrup formulations and to align the exemption framework with contemporary public health and safety requirements,” the notification said.
“The measure is expected to promote responsible distribution and sale of cough syrups while ensuring greater compliance with regulatory standards across the country,” it added.
Also read: Introducing Eggs Before Age One May Lower Allergy Risk by 17%, Says Study
Dr Kuldeep Kumar Grover, Associate Director, Pulmonology and Critical Care, CK Birla Hospital, Gurugram called it a
"a good initiative to include all syrup varieties, cough syrups included, under prescription medicines".
Cough syrups have substances that might lead to drowsiness, addiction, or drug interaction in patients who do not seek medical advice before taking the medicines.
"It is important to note that a cough could be a symptom of other serious conditions like infections, asthma, and allergies. Prescription-based access encourages proper evaluation, accurate treatment, and safer medication use," Grover said.
Dr. (Prof.) Mohsin Wali, former Physician to the President of India, said cough syrups and similar formulations often contain suppressants such as codeine and dextromethorphan (DXM), along with other solvents.
Dr. Wali, Senior Consultant and Head of Preventive Cardiology at Pacific One Health, recalled previous incidents in which contaminated Indian-made cough syrups were linked to deaths in Gambia and other African countries.
"Industrial-grade solvents were detected in some of these products, leading to kidney failure, severe metabolic acidosis, and, in some cases, death," he said.
According to Dr. Wali, the new notification will help curb the overuse, misuse, and addictive use of cough syrups while improving patient safety.
The Ministry notified an amendment to the Drugs Rules, 1945, through Gazette Notification G.S.R. 927(E) dated December 29, 2025, published in the Gazette of India Extraordinary, Part II, Section 3, Sub-section (i), dated December 30, 2025.
The amendment omits the word “Syrup” from Schedule K, Serial No. 13, Entry 7 under the heading “Class of Drugs.”
Schedule K of the Drugs Rules, 1945, provides exemptions from certain provisions of the Drugs and Cosmetics Act, 1940, and the rules framed under it for specified classes of drugs.
Before this amendment, Entry No. 13 of Schedule K permitted the sale of cough syrups in villages with a population of less than 1,000 without requiring compliance with certain retail sale licensing provisions.

With the omission of the word “Syrup” from the entry, this exemption will no longer apply to cough syrups.
Manufacturers, distributors, and retailers dealing with cough syrups have been advised to ensure strict compliance with the applicable licensing and regulatory requirements under the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.
Last year, India formally prohibited the use of certain commonly available OTC cough and cold medicines in children below the age of four.
The policy move, notified through a gazette notification, banned a fixed-dose combination (FDC) of Chlorpheniramine Maleate and Phenylephrine Hydrochloride—two ingredients commonly found in pediatric cough syrups.
The decision followed growing global concerns over the safety of these medicines in very young children, with India joining several countries that have introduced stricter regulations.
Countries including the United States, Canada, and the United Kingdom had previously issued guidelines or warnings regarding the use of OTC cough and cold medicines in young children.
© 2024 Bennett, Coleman & Company Limited